Avid Bioservices Inc (CDMO)
8.21
+0.54
(+7.04%)
USD |
NASDAQ |
May 02, 16:00
8.19
-0.02
(-0.24%)
After-Hours: 20:00
Avid Bioservices Shareholders Equity (Quarterly): 180.17M for Jan. 31, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
Date | Value |
---|---|
January 31, 2024 | 180.17M |
October 31, 2023 | 183.68M |
July 31, 2023 | 190.60M |
April 30, 2023 | 189.47M |
January 31, 2023 | 185.40M |
October 31, 2022 | 181.20M |
July 31, 2022 | 179.00M |
April 30, 2022 | 174.53M |
January 31, 2022 | 56.58M |
October 31, 2021 | 51.10M |
July 31, 2021 | 44.64M |
April 30, 2021 | 77.74M |
January 31, 2021 | 85.37M |
October 31, 2020 | 49.39M |
July 31, 2020 | 46.54M |
April 30, 2020 | 41.90M |
January 31, 2020 | 47.08M |
October 31, 2019 | 49.18M |
July 31, 2019 | 49.68M |
April 30, 2019 | 53.07M |
January 31, 2019 | 53.06M |
October 31, 2018 | 54.80M |
July 31, 2018 | 56.75M |
April 30, 2018 | 55.74M |
January 31, 2018 | 31.52M |
Date | Value |
---|---|
October 31, 2017 | 42.91M |
July 31, 2017 | 56.01M |
April 30, 2017 | 53.58M |
January 31, 2017 | 40.01M |
October 31, 2016 | 42.18M |
July 31, 2016 | 40.93M |
April 30, 2016 | 50.07M |
January 31, 2016 | 59.93M |
October 31, 2015 | 69.23M |
July 31, 2015 | 55.45M |
April 30, 2015 | 59.04M |
January 31, 2015 | 49.79M |
October 31, 2014 | 58.78M |
July 31, 2014 | 65.59M |
April 30, 2014 | 67.70M |
January 31, 2014 | 55.07M |
October 31, 2013 | 35.65M |
July 31, 2013 | 32.54M |
April 30, 2013 | 23.76M |
January 31, 2013 | 17.40M |
October 31, 2012 | 12.67M |
July 31, 2012 | 3.924M |
April 30, 2012 | 9.483M |
January 31, 2012 | 12.90M |
October 31, 2011 | 12.50M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
41.90M
Minimum
Apr 2020
190.60M
Maximum
Jul 2023
108.59M
Average
77.74M
Median
Apr 2021
Shareholders Equity (Quarterly) Benchmarks
Emergent BioSolutions Inc | 649.30M |
Creative Medical Technology Holdings Inc | 10.34M |
Viking Therapeutics Inc | 933.89M |
Stereotaxis Inc | 21.92M |
MAIA Biotechnology Inc | 0.4775M |
Shareholders Equity (Quarterly) Related Metrics
Total Assets (Quarterly) | 455.23M |
Total Liabilities (Quarterly) | 275.06M |
Debt to Equity Ratio | 0.7849 |
Current Ratio | 0.4648 |
Net Debt Paydown Yield | -0.06% |